Paper28299742
Virtual High-Throughput Screening for Matrix Metalloproteinase Inhibitors.
Choi JY and 1 other. Methods Mol Biol, 2017. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Virtual High-Throughput Screening for Matrix Metalloproteinase Inhibitors. Papers, record 28299742. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28299742
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Matrix Metalloproteinase Inhibitors | Major topic |
| Molecular Docking Simulation | Major topic |
| Small Molecule Libraries | Major topic |
| Binding Sites | |
| Computational Biology | |
| Crystallography, X-Ray | |
| Drug Evaluation, Preclinical | |
| High-Throughput Screening Assays | |
| Matrix Metalloproteinase 13 | |
| Models, Molecular | |
| Protein Conformation | |
| Structure-Activity Relationship |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10437989 | New drugs on the horizon: matrix metalloproteinase inhibitors. | Stem Cells | 1999 | https://conductscience.org/library/papers/10437989 | PubMed |
| 2 | 11254383 | Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state. | J Mol Biol | 2001 | https://conductscience.org/library/papers/11254383 | PubMed |
| 3 | 11274893 | Drug-like properties and the causes of poor solubility and poor permeability. | J Pharmacol Toxicol Methods | 2000 | https://conductscience.org/library/papers/11274893 | PubMed |
| 4 | 14711306 | Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions. | J Med Chem | 2004 | https://conductscience.org/library/papers/14711306 | PubMed |
| 5 | 15027865 | Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. | J Med Chem | 2004 | https://conductscience.org/library/papers/15027865 | PubMed |
| 6 | 15667143 | ZINC--a free database of commercially available compounds for virtual screening. | J Chem Inf Model | 2005 | https://conductscience.org/library/papers/15667143 | PubMed |
| 7 | 15734645 | Structural basis for the highly selective inhibition of MMP-13. | Chem Biol | 2005 | https://conductscience.org/library/papers/15734645 | PubMed |
| 8 | 16492144 | Structural interaction fingerprints: a new approach to organizing, mining, analyzing, and designing protein-small molecule complexes. | Chem Biol Drug Des | 2006 | https://conductscience.org/library/papers/16492144 | PubMed |
| 9 | 16675286 | Structure-based virtual screening of chemical libraries for drug discovery. | Curr Opin Chem Biol | 2006 | https://conductscience.org/library/papers/16675286 | PubMed |
| 10 | 17623656 | Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17623656 | PubMed |
| 11 | 18251495 | Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis. | J Med Chem | 2008 | https://conductscience.org/library/papers/18251495 | PubMed |
| 12 | 18289056 | Joint diseases and matrix metalloproteinases: a role for MMP-13. | Curr Pharm Biotechnol | 2008 | https://conductscience.org/library/papers/18289056 | PubMed |
| 13 | 19378467 | Assessment of the renal toxicity of novel anti-inflammatory compounds using cynomolgus monkey and human kidney cells. | Toxicology | 2009 | https://conductscience.org/library/papers/19378467 | PubMed |
| 14 | 19399780 | AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. | J Comput Chem | 2009 | https://conductscience.org/library/papers/19399780 | PubMed |
| 15 | 19422229 | Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13. | J Med Chem | 2009 | https://conductscience.org/library/papers/19422229 | PubMed |
| 16 | 19516266 | Stromal expression of MMP-13 is required for melanoma invasion and metastasis. | J Invest Dermatol | 2009 | https://conductscience.org/library/papers/19516266 | PubMed |
| 17 | 20196103 | Selective MMP13 inhibitors. | Med Res Rev | 2011 | https://conductscience.org/library/papers/20196103 | PubMed |
| 18 | 20450209 | Large-scale systematic analysis of 2D fingerprint methods and parameters to improve virtual screening enrichments. | J Chem Inf Model | 2010 | https://conductscience.org/library/papers/20450209 | PubMed |
| 19 | 20481653 | Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility. | Drugs | 2010 | https://conductscience.org/library/papers/20481653 | PubMed |
| 20 | 20929257 | Quo vadis, virtual screening? A comprehensive survey of prospective applications. | J Med Chem | 2010 | https://conductscience.org/library/papers/20929257 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MMP13 | 4322 | PubTator's text mining | https://conductscience.org/library/genes/4322 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28299742
GET https://conductscience.org/api/papers/v1/28299742/references?page=2